US2005176089A1PendingUtilityA1
Methods and devices for retrieving a subject's physiological history from a biological sample analysis
Priority: Dec 4, 2003Filed: Feb 8, 2004Published: Aug 11, 2005
Est. expiryDec 4, 2023(expired)· nominal 20-yr term from priority
Inventors:Michael Ehrlich
G01N 33/66G01N 2400/10
42
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Methods and devices for retrieving a subject's physiological history from a single sample or measurement are disclosed. Methods and devices for obtaining a blood glucose history from a single blood sample are disclosed.
Claims
exact text as granted — not AI-modified1 . A method of obtaining a subject's physiological history from a sample analysis, the method comprising the steps of:
(a) measuring an amount of a cellular modification for each of a plurality of cells from a biological sample; (b) sorting the cell measurements from step (a) as a function of the amount of modification; and, (c) determining a physiological history for the subject by analyzing the ordered cell measurements.
2 . The method of claim 1 , wherein the physiological history is indicative of a disease or disorder in the subject.
3 . The method of claim 2 , wherein the disease or disorder is diabetes.
4 . The method of claim 3 , wherein the diabetes is Type I diabetes.
5 . The method of claim 3 , wherein the diabetes is Type II diabetes.
6 - 18 . (canceled)
19 . A method of obtaining a cell distribution profile of a patient, the method comprising the steps of:
(a) obtaining a biological sample comprising intact cells; and (b) determining a cell distribution profile for a plurality of the intact cells using a procedure that sorts the intact cells based on an amount of a physiological variable in each of the sorted cells.
20 - 24 . (canceled)
25 . A method for recovering the blood glucose level history of a patient diagnosed with diabetes, the method comprising the steps of:
(a) obtaining a blood sample comprising intact cells (b) obtaining a cell distribution profile by sorting a plurality of the intact cells based on the amount of glycated hemoglobin in each cell; and, (c) determining the patient's glucose level history based on the cell distribution profile.
26 . The method of claim 25 , wherein the patient's blood glucose level history is obtained by comparing the patient's cell distribution profile to one or more reference profiles.
27 . The method of claim 25 , wherein the patient's blood glucose level history is obtained using an algorithm.
28 . The method of claim 27 , wherein the algorithm corrects for non-linearity in the rate of hemoglobin glycation.
29 . The method of claim 27 , wherein the algorithm uses patient specific input data.
30 . The method of claim 29 , wherein the patient specific input data is selected from the group consisting of the patient's age, gender, and weight.
31 . The method of claim 27 , wherein the algorithm uses a value for the average life span of a red blood cell.
32 . The method of claim 25 , wherein the intact cells are sorted using a procedure selected from the group consisting of chromatography, electrophoresis, mass spectrometry, and cell sorting.
33 . The method of claim 25 , comprising the additional step of determining whether the patient has Type I, Type II, or gestational diabetes.
34 . The method of claim 25 , comprising the additional step of determining a treatment regimen for the patient.
35 . The method of claim 25 , comprising the step of obtaining a second blood sample at a second time and performing steps (b) and (c) on the second blood sample.
36 . The method of claim 25 , wherein the glycosylated hemoglobin is labeled.
37 . A chromatography device for separating blood cells based on levels of glycosylated hemoglobin, the device comprising:
(a) a high pressure column comprising a sample chamber and a tapered exit hole; (b) a dynamic light scattering detector connected to the exit hole; and, (c) a gas powered injector connected to the sample chamber.
38 . An electrophoretic device for separating blood cells based on levels of glycosylated hemoglobin, the device comprising:
(a) a liquid flow column with a sample entry point and a plurality of collection points along the length of the column; and, (b) an electromagnetic field generator associated with the column, wherein the electromagnetic field is normal to the direction of the liquid flow.Join the waitlist — get patent alerts
Track US2005176089A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.